Aethlon Medical
AEMD
20 hedge funds and large institutions have $1.38M invested in Aethlon Medical in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.
640% more capital invested
Capital invested by funds: $187K → $1.38M (+$1.2M)
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
33% more funds holding
Funds holding: 15 → 20 (+5)
0.11% more ownership
Funds ownership: 0.04% → 0.14% (+0.11%)
Top Buyers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$318K |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$91.9K |
| 3 |
VF
Virtu Financial
New York
|
+$40K |
| 4 |
SCA
Sassicaia Capital Advisers
Jericho,
New York
|
+$15.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$13.3K |
Top Sellers
| 1 |
TSS
Two Sigma Securities
New York
|
-$6.41K |
| 2 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
-$5.79K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.73K |
| 4 |
Citigroup
New York
|
-$1.16K |
| 5 |
JP Morgan Chase
New York
|
-$768 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TSS
26
Two Sigma Securities
New York
| – | -$6.41K | -172 | Closed |
|
|
27
Citigroup
New York
| – | -$1.16K | -31 | Closed |
|
|
28
JP Morgan Chase
New York
| – | -$768 | -21 | Closed |
|
AEMD Hedge Fund Activity: Q4 2024 in Review
20 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q4 2024, worth a combined $1.38M — up 640% from $187K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new AEMD positions and 4 closed out — a net gain of 5 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Ikarian Capital, opening a new position worth an estimated $318K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $6.41K sold.
- 20 institutional investors held Aethlon Medical (AEMD) as of Q4 2024, up from 15 in Q3 2024.
- Funds reported $1.38M of Aethlon Medical stock for Q4 2024, up 640% quarter-over-quarter.
- 9 funds opened new Aethlon Medical positions in Q4 2024 and 4 closed out, a net change of +5 holders.
- The largest Aethlon Medical buyer in Q4 2024 was Ikarian Capital, an estimated $318K added.
- The largest Aethlon Medical seller in Q4 2024 was Two Sigma Securities, an estimated $6.41K sold.
Based on aggregated 13F filings for Q4 2024.